A STUDY REGARDING EFFICACY OF RIFAXIMIN IN HEPATIC ENCEPHALOPATHY DUE TO LIVER CIRRHOSIS
Journal Title: World Journal of Pharmaceutical and Medical Research - Year 2018, Vol 4, Issue 8
Abstract
Background: Hepatic encephalopathy is the second most common major complication in cirrhotic patients and it significantly impacts quality of life. Medicinal approaches for hepatic encephalopathy treatment and prevention mainly depends on ammonia-lowering strategies and non-absorbable disaccharides are currently considered the cornerstone therapy. Non-absorbable antibiotics, such as neomycin and paramycin, are effective in treatment of acute hepatic encephalopathy episodes but their prolonged use has serious side-effects. To overcome these limitations, rifaximin use has been proposed. Objective: To determine the efficacy of rifaximin in cases of chronic liver disease presenting with hepatic encephalopathy. Methodology: In this descriptive cases series study, which was conducted at Department of Medicine, Nishtar Hospital Multan from May 2017 to October 2017 for 6 months period. The cases of both genders with age range of 25–70 years, having CLD (Child Pugh Class B & C) and acute hepatic encephalopathy of grade II or more irrespective of the cause were included in this study. Hepatic encephalopathy was labeled according to the West Haven Criteria. The cases of hepatic encephalopathy were given Rifaximin in a dose of 550 thrice a day for 7 days and complete resolution of hepatic encephalopathy at 7th day was labeled as positive efficacy. Data was analyzed by using SPSS 20. Results: In this study, there were total 254 cases out of which 144 (56.6%) were males and 110 (43.33%) females. There were 104 cases in Child Pugh class B and 150 cases in Child Pugh class C. Efficacy of rifaximin was seen in 129 (50.7%) cases. The efficacy was significantly high in cases that had Child Pugh Class B. Efficacy was also significantly better in grade II encephalopathy 62/86 cases in contrast to 53/71 cases with grade III. Conclusion: Rifaximin is good antibiotic for gut flora but it relieves hepatic encephalopathy in only half of cases. It is significantly better in cases with Child pugh class B and with encephalopathy grade III.
Authors and Affiliations
Dr. Muhammad Sharief
Keywords
Related Articles
- EP ID EP665473
- DOI -
- Views 207
- Downloads 0
EBOLA VIRUS DISEASE – A CLINICAL REVIEW
Ebola virus is one of the most virulent pathogens, killing a very high proportion of patients within 5-7 days. Most patients developed high fever, head ache, diarrhea, vomiting and hemorrhagic manifestations. Since Ebola...
COMPARATIVE STUDY BETWEEN TRANSAREOLAR ENDOSCOPIC THYROIDECTOMY AND CONVENTIONAL THYROIDECTOMY
Background: Thyroidectomies using the open method are effective, well-tolerated and safe but involve transverse incision on the neck measuring 7–10 cm in length. Thyroid disorders are more common in women and they find t...
APPLICATION OF LEAN SIX SIGMA APPROACH IN INDIAN HOSPITALS TO IMPROVE PATIENT CARE
A rapidly growing population, booming economy, increasing urbanization which has expanded the middle class, increasing diseases needs continuous improvement in healthcare services. Increased competition and corporatizati...
NEUTROPHIL LYMPHOCYTE RATIO (NLR): A WELL ASSESSMENT TOOL OF GLYCEMIC CONTROL IN TYPE-2 DIABETIC PATIENTS
Background and Objective: Increased neutrophil lymphocyte ratio (NLR) is a marker as well as predictor of various cardiac and non-cardiac disorders. Our aim was to assess the relationship between NLR and different level...
ASSOCIATION BETWEEN FAT MASS AND OBESITY ASSOCIATED (FTO) GENE POLYMORPHISM (RS9939609) AND LIPID PROFILE IN TYPE2 DIABETIC OBESE IRAQI MALE
Background: Type 2 diabetes mellitus (T2DM) is the most widespread endocrine disease and one of the most acute medical and societal problems, as it leads to early disability and increased mortality from different complic...